February 2007

|
Volume 19 Issue 2
Case Report. A 32-year-old male suffered cardiac arrest out of hospital, was successfully resuscitated and transferred to our tertiary cardiac unit where we performed coronary angiography. Despite multiple attempts, the left main coronary artery (LMC…
A backup temporary pacing wire is often used in patients with heart block undergoing cardiac catheterization and percutaneous coronary intervention (PCI). It is particularly recommended for any patient undergoing rotational atherectomy or rheolytic t…
Case Report The patient is a 62-year-old male with a past medical history significant for hypertension, hyperlipidemia and coronary artery disease. In October 2004, he developed congestive heart failure and was diagnosed with severe mitral regurgitat…
Drug-eluting stents (DES) have, for the most part, replaced bare-metal stents (BMS) as a safe and effective therapeutic modality for treating coronary stenosis. Post-DES restenosis with sirolimus-eluting stents (SES) or paclitaxel-eluting stents (PES…
Targeted renal therapy (TRT) with direct intrarenal artery fenoldopam (FEN) infusions were used to treat a multifactorial acute renal failure (ARF) patient with acute limb ischemia, contrast-induced nephropathy (CIN) and sepsis. TRT was initially inf…
Hypertensive emergency (also referred to as malignant hypertension) is defined by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) as severe elevation in blood press…
Arterial revascularization by means of percutaneous transluminal angioplasty (PTA) is being increasingly used for the treatment of patients with severely symptomatic peripheral artery disease (i.e., those with critical limb ischemia). This phenomenon…
Bare-metal stents (BMS) lower the risk of restenosis and the need for repeat coronary revascularization compared to balloon angioplasty alone.1 The introduction of drug-eluting stents (DES) has further markedly decreased angiographic restenosis rates…
The choice of anticoagulant in patients undergoing percutaneous coronary intervention (PCI) has been the subject of intense investigation over the past decade. Ever since anticoagulation with heparin was observed to be an essential treatment in patie…
Coronary stenting has demonstrated a consistent ability to reduce restenosis rates compared with percutaneous “plain old” balloon catheter angioplasty. However, in-stent restenosis has long remained the major limitation of coronary stenting. Recent r…